The Minnesota Department of Health has found that about 83,000 Minnesotans a year received chronic pain procedures during a three-year period. MDH was able to conduct this analysis for the ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...

Neck or cervical pain is a common problem, affecting millions of people each year. Most of the time, a stiff neck with pain and inflammation can be treated at home with ice or heat pads, light ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Research indicates that musculoskeletal surgery shouldn't be the first stop for a health plan member in chronic pain.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...